In particular, Hernández-Corbacho et al. have shown that DGAT2 is constitutively activated in the liver, breast, thyroid, prostate, and pancreatic cancers [26] and that MCF7 cells express higher levels of DGAT2 than DGAT1 [27]. This evidence concerns the gene DGAT2 and familial pancreatic carcinoma.